e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Ritesh Agarwal, Sahajal Dhooria, Inderpaul S. Sehgal, Ashutosh N. Aggarwal, Mandeep Garg, Biman Saikia, Arunaloke Chakrabarti
Source:
Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ritesh Agarwal, Sahajal Dhooria, Inderpaul S. Sehgal, Ashutosh N. Aggarwal, Mandeep Garg, Biman Saikia, Arunaloke Chakrabarti. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J 2016; 47: 490-498
Year: 2016
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001
Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003
A randomized, placebo-controlled trial using anti-IgE to treat allergic bronchopulmonary aspergillosis
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
Source: Eur Respir Rev 2014; 23: 149-152
Year: 2014
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 301s
Year: 2007
Severe asthma exacerbations with eosinophilic bronchitis: a randomized controlled comparison of the anti-inflammatory effects of deflazacort
vs.
prednisone
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006
Effectiveness of itraconazole and systemic steroids in the treatment of ABPA
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
Place of azoles in the treatment of allergic bronchopulmonary candidiasis
Source: Eur Respir J 2006; 28: Suppl. 50, 52s
Year: 2006
Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series)
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
Source: ERJ Open Res, 5 (4) 00056-2019; 10.1183/23120541.00056-2019
Year: 2019
Efficacy and safety of ciclesonide in the treatment of patients with persistent allergic or non-allergic asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide
Source: Eur Respir J 2002; 20: 127-133
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept